Leukemic phase of ALK(+) anaplastic large-cell lymphoma, small-cell variant: clinicopathologic pitfalls of a rare entity.

[1]  A. Ferrando,et al.  Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia. , 2012, Blood.

[2]  L. Medeiros,et al.  Flow cytometric immunophenotyping of anaplastic large cell lymphoma. , 2009, Archives of pathology & laboratory medicine.

[3]  R. Attanoos,et al.  Small cell variant of anaplastic large cell lymphoma: a 10‐year review of the All Wales Lymphoma Panel database , 2009, Histopathology.

[4]  Stefano A Pileri,et al.  ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. , 2008, Blood.

[5]  R. Lai,et al.  Pathobiology of ALK+ anaplastic large-cell lymphoma. , 2007, Blood.

[6]  K. Elenitoba-Johnson,et al.  Anaplastic Large Cell Lymphoma. , 2007, American journal of clinical pathology.

[7]  Robert E. Lewis,et al.  Aberrant Myeloid Marker Expression in Precursor B‐Cell and T‐Cell Leukemias , 2007, Experimental and molecular pathology.

[8]  Lauren B. Smith,et al.  Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature , 2007, Annals of Hematology.

[9]  H. Wong,et al.  Report of three cases and review of the literature , 2004 .

[10]  F. Behm,et al.  ALK-Positive Anaplastic Large Cell Lymphoma With Leukemic Peripheral Blood Involvement Is a Clinicopathologic Entity With an Unfavorable Prognosis , 2003 .

[11]  F. Behm,et al.  ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis. Report of three cases and review of the literature. , 2003, American journal of clinical pathology.

[12]  Shiyong Li,et al.  Immunophenotypic analysis of anaplastic large cell lymphoma by flow cytometry. , 2003, American journal of clinical pathology.

[13]  S. Mori,et al.  CD30 and the NPM‐ALK fusion protein (p80) are differentially expressed between peripheral blood and bone marrow in primary small cell variant of anaplastic large cell lymphoma , 2002, American journal of hematology.

[14]  M. Kumar,et al.  CD13-positive anaplastic large cell lymphoma of T-cell origin--a diagnostic and histogenetic problem. , 2000, Archives of pathology & laboratory medicine.

[15]  D. Jong,et al.  Leukaemic expression of anaplastic large cell lymphoma with 46,XX,ins(2;5)(p23;q15q35) in a child with dihydropyrimidine dehydrogenase deficiency , 2000, Leukemia.

[16]  G. Delsol,et al.  Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four cases , 1999, British journal of haematology.

[17]  H. Stein,et al.  Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. , 1996, Blood.

[18]  J. Downing,et al.  Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. , 1995, Blood.